Latest From Francesca Bruce
The pharmaceutical legislation overhaul offers some solutions to the problem of immature applications.
The number of conditional marketing authorization non-renewals could increase.
El Salvador has approved a new law that will establish a new regulatory body responsible for authorizing medicines and setting prices.
NHS England has committed to two pilots on innovative pricing models for advanced therapies under the UK’s new voluntary pricing agreement for new medicines.
El Salvador has approved a law that will establish a new regulatory body responsible for authorizing medicines and setting prices.
CSL’s Hemgenix is the latest expensive gene therapy to come under scrutiny from the BeNeLuxA cross-country coalition.